Cefoxitin esterified prodrug compound and oral preparations

A technology of cefoxitin and prodrugs, which is applied in the field of pharmaceutical compounds, can solve the problems of not being able to meet the needs of different groups of people, inconvenient use, single usage of cefoxitin sodium, etc., and achieve the effect of drug safety, time saving and definite curative effect

Inactive Publication Date: 2012-08-15
李莎
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The present invention aims to overcome the shortcomings of single usage of cefoxitin sodium for injection, inconvenient use, and inability to meet

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses an esterified prodrug compound and salt forming compounds and oral preparations thereof. The prodrug compound is shown in the structural formula (IV) in the specification, takes cefoxitin as an active ingredient and can exist in the form of salts. The prodrug compound has the following advantages that a lipophilic group acetoxy-1-halothane is introduced on the basis of cefoxitin to esterify carboxyl to become the esterified prodrug, thus providing an active pharmaceutical ingredient changing the original dosage forms; orally taken, the esterified prodrug not only relieves pains suffered by the patients during injection but also is not only used in professional organizations, thus saving time and widening the application range of the drug; and the esterified prodrug has a confirmed curative effect.

Description

technical field The invention relates to a class of esterified prodrug compounds with the second-generation cephalosporin antibiotic cefoxitin as an active ingredient, a salt-forming compound and oral preparations thereof, belonging to the field of pharmaceutical compounds. Background technique Cefoxitin Sodium is the second-generation semi-synthetic cephalosporin (cephamycin antibiotic), developed by Merck & Co. of the United States. It was launched in 1974, and then listed in more than 20 countries around the world. In 1992, the injection was launched in China, and in 2002 The API was launched in China in 2009. The trade name of cefoxitin sodium for injection listed in the United States is "MEFXOIN". ? " (or "Meifuxian ? ”), FDA-approved specifications are 1.0, 2.0g. It is mainly used clinically for sensitive bacteria (such as: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Proteus, Morganella morganii, Providencia , Peptostreptococcus, Bacteroides, etc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D501/57C07D501/04A61K31/546A61P31/00
Inventor 李莎
Owner 李莎
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products